# Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

> **NCT07370519** · PHASE2 · RECRUITING · sponsor: **Shenzhen People's Hospital** · enrollment: 388 (estimated)

## Conditions studied

- Androgenetic Alopecia (AGA)

## Interventions

- **BIOLOGICAL:** Lactobacillus reuteri
- **BIOLOGICAL:** Inactivated Lactobacillus reuteri
- **DRUG:** 5% Minoxidil
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT07370519
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-25
- **Primary completion:** 2027-01
- **Final completion:** 2027-06
- **Target enrollment:** 388 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07370519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07370519, "Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07370519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*